Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Cancer Patients

By
Justin.choi
-
0
25
Investigators examined the role of the CD137+ T cells in the improvement of patients’ selection for immunotherapy treatment.
[Clinical Cancer Research]

Sorry, but the selected Zotpress account can't be found.

Abstract